FEATURED ARTICLES
Navigating The New EU Pharmaceutical Legislation: Key Implications For Pediatric Drug Development
UCB’s Senior Development Strategy Lead Pediatrics Martine Dehlinger-Kremer, Ph.D., discusses updates to the new EU Pharma legislation and how they impact pediatric drug development, including earlier pediatric investigational plans .
-
Before AI Can Transform Clinical Trials, It Needs More Patient Data
King’s College London Professor Maddy Parsons says AI won't improve clinical trials — unless researchers begin collecting richer biological data, embracing diversity, and treating every clinical trial as learning opportunity.
-
How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients
Regeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.
-
i-Cubed Used End-To-End AI In A Proof-Of-Concept Trial. Here's What They Learned
Discover how well AI fared in document generation, patient engagement, data integration, and more in an end-to-end proof-of-concept study run by i-Cubed.